IP Library Granted Patent US 7,638,486
Granted Patent B2
US 7,638,486 · App. 11/457,091 · Granted Dec 29, 2009

Method for promoting hard tissue formation

Assignee: Acologix, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,638,486
App. No.
11/457,091
Granted
Dec 29, 2009
Kind
B2
Abstract

Formulations and methods to promote biological processes to form or regenerate new hard tissues such as bones, cartilage, and/or dental tissues are disclosed. The formulation comprising two proteins is administered to enhance biological activities of a hard tissue growth and differentiation factor characterized by specific and selective upregulation and/or extension of the retention time of the intracellular enzymes and signaling molecules that play important roles to proliferate, differentiate, maturate, and/or mineralize the hard tissue forming cells.

Claims (8)

1. A method of enhancing hard tissue formation activity, comprising:

administering to a patient an effective amount of the peptide of SEQ ID NO:8; and

further administering to the patient an effective amount of recombinant human bone morphogenic protein-2 (rhBMP-2);

wherein the ratio of the rhBMP-2 to the peptide of SEQ ID NO:8 is in a range of 1:5 or more allowing the peptide and the protein to act on hard tissue forming cells and thereby enhance hard tissue formation activity.

2. The method of claim 1 wherein the hard tissue forming cells are cells chosen from the group of: (a) cells of a lineage of osteoblast wherein the hard tissue is in the form of bone tissue; (b) cells of a lineage of ameloblast wherein the hard tissue is in the form of enamel; (c) cells of a lineage of odontoblast wherein the hard tissue is in the form of dentin; and (d) cells of a lineage of cementoblast wherein the hard tissue is in the form of cementum.

3. The method of claim 1 , wherein the peptide and the protein are administered by injection.

4. The method of claim 1 , wherein the peptide and the protein are administered at the same time.

5. The method of claim 4 , wherein the peptide and the protein are administered on an absorbable collagen sponge (ACS).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2011
From: ACOLOGIX, INC.
To: ORTHOTROPHIX, INC.
Reel/Frame 026716/0793 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2007
From: LAZAROV, MIRELLA; MIDDLETON-HARDIE, CATHERINE; ROSEN, DAVID
To: ACOLOGIX, INC.
Reel/Frame 019276/0290 →
Continuity (6)
Provisional Application 6080520100 · Jun 19, 2006
Provisional Application 6080332700 · May 26, 2006
Provisional Application 6074725500 · May 15, 2006
Provisional Application 6074714300 · May 12, 2006
Provisional Application 6070051800 · Jul 18, 2005
Related Publication 20080096798A1 · Apr 24, 2008